USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS
|
|
- Gillian Murphy
- 8 years ago
- Views:
Transcription
1 USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS
2 APPLICABILITY (WITH REGARD TO CONTROLLED SUBSTANCES) This presentation is applicable to: Animal and non-animal research This presentation is mostly applicable to: Teaching and analytical testing (please contact EH&S for specifics) This presentation is not applicable to: Human Research Weill Cornell Medical College Clinical/Hospital/Individual Medical, Pharmaceutical or Veterinary Practice
3 RESOURCE This training is an OVERVIEW For details, links and forms, see the EH&S guidance document: Research Use of Controlled Substances
4 REGULATIONS
5 REGULATORS Controlled substances are regulated by the: United States Federal Drug Enforcement Agency (DEA) New York State Department of Health (NYSDOH), Bureau of Narcotic Enforcement (BNE)
6 REGULATIONS Each has written laws and regulations: DEA Regulation: Title 21 CFR, Part Law: Title 21 USC, Controlled Substances Act NYSDOH Regulation: Part 80. Rules and Regulations on Controlled Substances Law: Article 33. Controlled Substances
7 RESEARCH USE Research use and possession of controlled substances requires: NYSDOH licensing DEA registration Adherence to all controlled substances laws and regulations
8 CONTROLLED SUBSTANCES DEFINITION & SCHEDULES
9 CONTROLLED SUBSTANCES DEFINITION A controlled substance is: a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V (CSA, Title 21, Section 802, (6)) The five schedules (I-V) range from Schedule I - the most stringently controlled (primarily illegal drugs) Schedule V - the least restrictive
10 SCHEDULES I-V Drugs or substances are assigned to schedules based on their current acceptable medical use and abuse/dependency potential
11 DEA & NYSDOH SCHEDULES Both the DEA and NYSDOH have schedule lists for drugs In general, the NYSDOH controlled substances listings reflect the DEA list BUT there are exceptions
12 NOTABLE EXCEPTIONS Some notable exceptions: Human chorionic gonadotropin (HCG) HCG is NOT a DEA controlled substance HCG IS a NYSDOH controlled substance (schedule III) Anabolic Steroids (example: testosterone) DEA schedule III NYSDOH schedule II The stricter definition takes precedence. Thus, A controlled substance license is needed to purchase HCG in NYS Testosterone must be ordered, stored and used as a schedule II drug in NYS
13 SCHEDULE MISMATCHES When NYSDOH and DEA schedules differ, so will license and registration schedule privileges: To purchase HCG in NYS NYSDOH License: schedule III privileges DEA Registration: not required To purchase testosterone in NYS: NYSDOH License: schedule II privileges DEA Registration: schedule III privileges. This can cause confusion when a NYSDOH license holder applies for DEA registration. NYSDOH handles this on a case-by-case basis if DEA rejects the application because of scheduling mismatches.
14 LICENSING AND REGISTRATION
15 NYSDOH LICENSING License Class There are different license classes depending on the work being conducted: Class 4 - Researcher (Schedules II-V) Class 5 - Instructional Activities (Schedules II-V) Class 7 - Research and Instructional Activities (Schedule I) Class 8 - Analytical Laboratory Researchers may have to have more than one license, depending on the work being conducted Researcher with schedule I substances Special procedures apply. Please contact EH&S for guidance Typical research license at Cornell is Class 4
16 NYSDOH LICENSE TYPES There are 2 main types of research licenses Individual Institutional Note that Cornell University does NOT hold an Institutional License An Institutional License here means a license held by a Department or Unit
17 NYSDOH INDIVIDUAL LICENSE Individual assumes complete responsibility for activities conducted under the license Must be a Faculty Member or Senior Staff Member to hold a license Research protocols must be submitted to NYSDOH for approval Protocols must be that of the Licensee Controlled substance activities are limited to the scope of the approved protocol(s)
18 NYSDOH INSTITUTIONAL LICENSE Department or unit must have an Oversight Committee to administer the program which includes: Maintaining the NYSDOH license and DEA registration Assuming responsibility for researchers operating under the license Reviewing protocols, giving use authorization, reporting to NYSDOH Ordering, receiving, storage, disposal, recordkeeping, security, training
19 INSTITUTIONAL LICENSE CONSIDERATIONS The responsibilities of administering an Institutional License are not insignificant Departments or units interested in applying for institutional licensing must first contact EH&S for guidance
20 LICENSE APPLICATION & RENEWAL New applicants (individual and institutional) Contact EH&S for guidance before applying Must obtain the NYSDOH license BEFORE applying for DEA registration NYSDOH will make a site visit Renewals Licenses must be renewed every 2 years
21 DEA REGISTRATION There are 2 main types of research DEA registrations Researcher with schedule II-V substances Almost all research at Cornell will be covered under schedules II-V The applicant selects the schedules of the drugs to be allowed on the registration Researcher with schedule I substances Special procedures apply. Please contact EH&S for guidance
22 DEA REGISTRATION The DEA does not have categories for Individual and Institutional Licenses. However, NYSDOH Individual Licensees register as an individual NYSDOH Institutional Licensees register as a business Protocols do not have to be submitted EXCEPT for research with schedule I substances Expect DEA to follow up with questions, especially regarding security
23 REGISTRATION APPLICATION & RENEWAL New applicants (DEA Form 225) Again, all new applicants must obtain a NYSDOH license BEFORE applying for a DEA registration DEA will make a site visit at their discretion Renewals (DEA Form 225a) Registration must be renewed every year DEA prefers this done on-line
24 PROFESSIONAL MEDICAL LICENSES Many researchers at Cornell are medical professionals (e.g. DVM, MD) and hold professional NYS licenses and DEA registrations that allow them to use or prescribe controlled substances as part of their medical practice Research use of controlled substances IS NOT covered under these licenses/registrations Medical professionals must obtain research NYSDOH licenses and research DEA registrations separate from their professional license/registration in order to conduct research using controlled substances (sorry!)
25 MIXING AND MATCHING LICENSES AND REGISTRATIONS Each NYSDOH license must have a corresponding DEA registration associated with it No mixing/matching of individual/institutional/professional licenses or registrations is allowed Examples of combinations NOT allowed An institutional NYSDOH research license and an individual research DEA registration An individual NYSDOH research license and an individual medical professional DEA registration
26 USE IN RESEARCH
27 DEFINITIONS OF ROLES AT CORNELL Licensee person or department/unit holding an individual or institutional NYSDOH license and corresponding DEA registration. The licensee has signature authority (can not be delegated) Supervisor of Controlled Substance Activity (Responsible Individual) at Cornell, this role is assumed by the Licensee Individual Licensee - Licensee acts as Supervisor of Controlled Substance Activity and Signatory Institutional Licensee Department Chair act as Supervisor of Controlled Substance Activity, Signatory, and Chair of Oversight Committee
28 DEFINITIONS OF ROLES AT CORNELL CONTINUED Material Manager manages DEFINED and LIMITED day-to-day activities under the license Not required if the Licensee assumes the responsibilities directly Should be a staff member (not student) Role should be part of job description Does not have signature authority Must fill out an Personnel Screening form Authorized User an individual (faculty, staff or graduate student) authorized by the Licensee to work with controlled substances in defined project(s) Must fill out an Personnel Screening form
29 ADDITIONAL DEFINITIONS SPECIFIC FOR INSTITUTIONAL LICENSEES Oversight Committee The committee overseeing an Institutional License. The Department Chair serves as the Chair of the Oversight Committee, Signatory and Supervisor of the Institutional License. Senior Authorized User Faculty or senior staff member approved by the Oversight Committee to work with controlled substances under the Institutional License Must fill out a Personnel Screening form May in turn appoint members of their laboratory as Authorized Users
30 SCOPE Only Licensee s and Authorized/Senior Authorized Users may work with controlled substances Controlled substance work is limited to the scope of the approved protocol Work only with drugs specified in the protocol Work only on the approved protocol
31 TRAINING - REQUIRED EH&S Overview Course (what you are taking now) Review CU EH&S document Research Use of Controlled Substances Familiarity with DEA and NYSDOH controlled substance rules and regulations Training specific to the protocol and license (given by the Licensee or Senior Authorized User to Authorized Users working under their license)
32 SAFETY Some controlled substances may also present safety hazards to the user. For example: Injections may expose the user to biosafety hazards Chloral hydrate (schedule IV) may cause irritation, burns and central nervous system depression Please read the MSDS, the Cornell Laboratory Safety Manual, and take appropriate EH&S safety training when biological, chemical or physical hazards are present
33 PURCHASING Licensee must place (sign) the order Senior Authorized Users, working under an Institutional License, must submit orders to the Supervisor of Controlled Substance Activities (assigned by the Licensee) Orders must be placed with suppliers and manufacturers, NOT through a pharmacy All purchases must be accompanied by license and/or registration information Suppliers typically require a copy of the DEA registration Obtaining drugs for research using a prescription is NOT ALLOWED (NYSDOH rules)
34 PURCHASING SCHEDULES I & II Orders for schedule I and II drugs must be accompanied by DEA Form 222 The DEA gives the Licensee these forms Once the drug has been ordered, copies of Form 222 must be kept along with the other schedule I & II records
35 RECEIVING All purchases must be delivered to the Licensee s address For Institutional Licensees Purchases must be shipped to the address on the DEA application (not individual Senior Authorized Users) Main stocks should be kept in department central storage Working stocks may be allocated to Senior Authorized Users
36 INVENTORY & RECORD KEEPING The main components are: Record of Receipt Record of Use (including disposal) Biennial Inventory Records for schedules I and II drugs must be kept separate from all other records All records must be kept for 5 years from the date of the last transaction Records must be readily retrievable
37 RECORDS OF RECEIPT ( RECEIPT LOG ) Record must contain date of receipt, name and address of vendor, and the type and quantity of controlled substance received An invoice from the vendor is sufficient, provided it contains the above information Records must be kept in a separate file Such as a notebook specific for controlled substances Records for schedules I and II drugs must be kept separate from all other records Duplicate copies of DEA form 222 (for schedule I and II drugs) must also be kept
38 RECORD OF USE ( USE LOG ) The record ( Use Log ) must include: Name of the person(s) allowed to control and use the drug and type, form and initial quantity of the drug Amount dispensed, purpose, date, signature of user, and balance left Record of disposal including: Lost or stolen Spilled Disposed (such as unused or expired) Destroyed
39 INVENTORY Biennial Inventory (once every 2 years) required by NYSDOH and DEA Does not have to be turned in but does need to be available upon inspection Keep inventory with other controlled substance records
40 INSTITUTIONAL LICENSEES ADDITIONAL RECORDS Record keeping for Institutional Licensees will be more complex than for individuals Institutional Licensees will need to keep additional records including: Senior Authorized User authorization Transfer to Senior Authorized Users Central receiving and inventory Records of disposal, spills, or loss
41 TRACKING NUMBER It is highly advised, especially for Institutional Licensees, that each commercial unit of controlled substance be given a tracking number Also advised for Individual Licensees with multiple projects and drugs EH&S can provide templates for record keeping
42 STORAGE Needs to be in place before application for license is submitted to NYSDOH Storage requirements depend on: Drug schedule Main or working stock Usually storage must be either a Vault or safe Double door, double locked cabinet Different licensees or senior authorized users cannot share storage cabinets/vaults
43 VAULT OR GSA CLASS 5 SAFE Minimum requirement for main stocks of schedules I & II If it weighs less than 750 lbs, must be bolted or cemented to the floor Various other specifications apply Most Institutional Licensees will need a GSA Class 5 Safe or the equivalent for central departmental storage
44 DOUBLE DOOR, DOUBLE LOCKED CABINET Appropriate for: Working stocks of schedules I-V Main stocks of schedules III-V Specifications: Stainless steel, bolted to wall or a fixed surface Inner and outer door, each with separate keys Combination lock not acceptable Suits many applications at Cornell. Also referred to as a Drug Box or Narcotic Cabinet
45 ACCESS RESTRICTIONS Area in which the controlled substances are kept should be limited in access to a minimum number of personnel Keys for the Narcotic Cabinet or combination for the safe should be under the control of the Licensee
46 DIVERSION, LOSS OR THEFT Authorized Users and Senior Authorized Users should report any knowledge of diversion, loss or theft to the Licensee The Licensee should report any knowledge of diversion, loss or theft to: Cornell Police EH&S In addition, the Licensee is required to report to DEA and NYSDOH immediately and file official forms DEA and DOH-2094 This is the Licensee s responsibility
47 SPILL PROCEDURES RECOVERABLE MATERIAL If there is recoverable material, collect it and dispose of it as described in the disposal slide (coming up)
48 SPILL PROCEDURES NON-RECOVERABLE MATERIAL Non-recoverable breakage or spill constitutes a loss for NYSDOH but not DEA Actions taken must satisfy both DEA: Document the circumstances in the Use and Inventory Records 2 witness who observed the spill/breakage must sign the records NYSDOH: The Licensee must report the spill to NYSDOH using form DOH-2094 Also document loss in records (DEA procedures will satisfy this)
49 IMPORT AND EXPORT This can be very complicated In addition to specific procedures required by DEA, other regulatory bodies, regulations and laws may come into play when bringing controlled substances in or out of different countries or even different states Licensees contemplating import or export must thoroughly research applicable requirements and procedures and submit a proposal to EH&S before proceeding
50 TRANSFER No transfer of controlled substances between research groups is allowed at Cornell
51 DISPOSAL Disposal must be arranged by the Licensee* by either: Return to the distributor or manufacturer Disposal through a reverse distributor Controlled substances cannot be disposed of by EH&S *A Senior Authorized User, working under an Institutional Licensee, cannot independently arrange for disposal
52 RETURN TO MANUFACTURER OR DISTRIBUTOR Some manufacturers or distributors will permit the return of unused controlled substances Must check with the manufacturer/distributor May accept unused or expired substances Unlikely to accept unpackaged items (such as solutions made from controlled substances)
53 REVERSE DISTRIBUTION A Reverse Distributor is a entity permitted to handle unwanted, unusable, or outdated controlled substances acquired from another DEA registrant The substances are then either returned to the manufacturer or properly destroyed
54 REVERSE DISTRIBUTION RECOMMENDED ROUTE This is the recommended route for disposing of controlled substances It is usually done by mail, accompanied by the appropriate forms DOT training is NOT required provided the controlled substance does not also fit the definition of a hazardous material NYSDOH has a list of approved Reverse Distributors Cost is the responsibility of the Licensee
55 ON-SITE DESTRUCTION NYSDOH approval for on-site destruction is limited and given on a case-by-case Cost savings is not one of these circumstances On-site destruction requires authorization from NYSDOH (Form DOH-2340) and prior approval from EH&S
56 POSSESSION WITHOUT A LICENSE Possession of controlled substances by a researcher with an expired DEA registration or NYSDOH license may be considered illegal possession Licensee is responsible for appropriate disposal of any controlled substances prior to letting a license/registration expire
57 ABANDONED SUBSTANCES Abandoned controlled substances are very problematic EH&S will assist departments in disposal of abandoned substances that were obtained PRIOR to the substance being classified as controlled (e.g. clean outs of very old labs)
58 SUBSTANCES ABANDONED BY A LICENSEE Controlled substances left by a Licensee (even if their License is expired or if they have left Cornell) are still the Licensee s responsibility The Licensee s department should make every effort to contact the Licensee If that is unsuccessful, EH&S will provide guidance to the Department as to their options Any associated costs will be borne by the Department
59 SUMMARY This training has provided an overview of regulatory requirements and Cornell expectations. Please remember though, that Requirements can change Specific situations may need to be addressed It is the Licensee s responsibility to be familiar with and adhere to all regulatory requirements For details, links and forms, see the EH&S guidance document Research Use of Controlled Substances EH&S can provide guidance and assistance
60 THANK YOU FOR TAKING THIS TRAINING! To receive credit, go to CU Learn and take the quiz. If you are a: Licensee or Senior Authorized User Take quiz: 5190 (EHS-Research Use of Controlled Substances for Licensee/Senior Authorized Users) Authorized User or Other Take quiz: 5195 (EHS-Research Use of Controlled Substances for Authorized Users) Instructions for accessing CU Learn
61
May 2010 Rhonda Dash, MPH Director, Research Compliance
May 2010 Rhonda Dash, MPH Director, Research Compliance Introduce the new Director of Research Compliance Review Applicable Federal Regulations Review Applicable State Regulations Review UNTHSC new Policies
More informationControlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
More information3341-7-09 Use of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
More informationControlled Substance Policy for Research
Controlled Substance Policy for Research The University of North Carolina at Greensboro Approved 7/1/2013 I. Purpose University researchers may, in the course of lawful research, teaching or testing, find
More informationUCSD Controlled Substances Program Procedures
UCSD Controlled Substances Program Procedures I. PROCEDURE A. Controlled Substance Use Authorization Requirements A Controlled Substance Use Authorization (CSUA) must be completed prior to acquiring controlled
More informationDefinitions: The Certification of Exemption memorandum must be signed by the principal investigator s dean or department chair.
University of Pittsburgh Guidelines for the Ordering and Use of Prescription Drugs and Devices and Controlled Substances for Non- Clinical Laboratory Research Definitions: 1. Authorized Agent(s) of the
More informationTitle 16. Board of Pharmacy Proposed Text
Title 16. Board of Pharmacy Proposed Text Proposal to add new Article 9.1 of Division 17 of Title 16 of the California Code of Regulations and a new Article title as follows: Article 9.1. Prescription
More informationAdministrative Policy
Administrative Policy Number: 411 Effective: 4/7/2011 Supersedes: n/a Page: 1 of 8 Subject: Use of Controlled Substances in Research 1.0. PURPOSE: The purpose of this policy is to set forth procedures
More informationNarcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
More informationUse of Controlled Substances In Research Manual
Use of Controlled Substances In Research Manual August 2015 This manual and all forms are posted online at: http://www.research.vcu.edu/controlled_substances/cs_manual.pdf Questions about the information
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationUW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
More informationUsing Controlled Substances in Research, Teaching, and Veterinary Care at UAB
Using Controlled Substances in Research, Teaching, and Veterinary Care at UAB I. The DEA and Controlled Substances II. The Federal Drug Enforcement Administration (DEA) is authorized to prevent, detect,
More informationARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:
ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:
More informationSTANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES
STANDARD OERATING ROCEDURE #401 CONTROLLED SUBSTANCES 1. UROSE This Standard Operating rocedure (SO) describes procedures for acquiring, storing, using and discarding controlled substances. 2. RESONSIBILITY
More informationFebruary 19, 2013. Dear Ms. Leonhart:
Ms. Michele M. Leonhart Administrator Drug Enforcement Administration U.S. Department of Justice 8701 Morrissette Drive Springfield, VA 22152 Re: Notice of proposed rulemaking on Disposal of Controlled
More informationDEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and
More informationUTCVM PHARMACY STANDARD OPERATING PROCEDURES
UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy
More informationWisconsin Department of Regulation & Licensing
TYPE OR PRINT CLEARLY Wisconsin Department of Regulation & Licensing Mail To: P.O. Box 8935 Madison, WI 53708-8935 1400 E. Washington Avenue Madison, WI 53703 FAX #: (608) 261-7083 Phone #: (608) 266-2112
More information105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS
105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription
More informationMESSAGE FROM THE ADMINISTRATOR
i ii MESSAGE FROM THE ADMINISTRATOR The Drug Enforcement Administration (DEA) is pleased to provide this guideline to assist in the understanding of the provisions of the Controlled Substances Act of 1970
More informationUniversity of California Business and Finance Bulletin
University of California Business and Finance Bulletin Office of the Executive Vice President Business Operations Number BUS 50 Controlled Substances Program Best Practices Guide http://www.ucop.edu/ucophome/policies/bfb/bus50.html
More informationROCHESTER AREA SCHOOL DISTRICT
No. 210 SECTION: PUPILS ROCHESTER AREA SCHOOL DISTRICT TITLE: USE OF MEDICATIONS ADOPTED: August 11, 2008 REVISED: August 25, 2014 210. USE OF MEDICATIONS 1. Purpose The Board shall not be responsible
More informationPursuant to the authority vested in the Commissioner of Health by Article 33 of the
Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health
More informationDisposal of Pharmaceuticals, and their empty containers, in the Workplace
Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since
More informationSPECIAL USE AUTHORIZATION APPLICATION (Instructions to Applicants)
Mail To: P.O. Box 8935 Ship To: 1400 E. Washington Avenue Madison, WI 53708-8935 Madison, WI 53703 FAX #: (608) 261-7083 E-Mail: dsps@wisconsin.gov Phone #: (608) 266-2112 Website: http://dsps.wi.gov CONTROLLED
More informationFERNDALE AREA SCHOOL DISTRICT
No. 210 SECTION: PUPILS FERNDALE AREA SCHOOL DISTRICT TITLE: MEDICATIONS ADOPTED: AUGUST 1985 REVISED: DECEMBER 6, 2000 MAY 9, 2007 JUNE 17, 2009 JUNE 18, 2014 210. MEDICATIONS REVISED: 1. Purpose The
More informationEight Important Principles For Managing Prescription Medications In the Athletic Training Room
Eight Important Principles For Managing Prescription Medications In the Athletic Training Room Robert Nickell, RPh, FAPO, FCPHA, FACA Sports Pharmacist USA Team Pharmacist President and CEO, Sportpharm
More informationLouisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists
Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For
More informationPatient Safety. Road Map to Controlled Substance Diversion Prevention
Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/
More informationCHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
More information- 1 - First Time Pharmacy Managers (Revised 02/02/2011)
State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO
More informationDrug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
More informationSchool Based Emergency Medicine Class D Clinic
School Based Emergency Medicine Class D Clinic NM Board of Pharmacy Policy and Procedure Manual School Based Emergency Medicine Class D Clinic REQUIRED FOR COMPLIANCE NM Board of Pharmacy Approved Policy
More informationAmbulatory Surgical Centers Frequently Asked Questions
Ambulatory Surgical Centers Frequently Asked Questions Index Top General Definitions Compliance with State Licensure Laws Governing Body and Management Surgical Services Quality Assessment and Performance
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More information12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
More informationDISPOSAL OF CONTROLLED SUBSTANCES
DISPOSAL OF CONTROLLED SUBSTANCES WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association Outline of Today s 2/2/2 PRESENTER Jan Harris Director, EHS Customer Compliance
More informationDate Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication
POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date
More informationElectronic Prescribing In New York State
Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe
More informationFREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationEPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More information11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
More informationThe Fundamentals of Inventory Management
The Fundamentals of Inventory Management Article brought to you by Angela Aisbet, Inventory Management Consultant for MWI. To inquire about additional information about our Inventory Management Consultation
More informationMASSACHUSETTS. Downloaded January 2011
MASSACHUSETTS Downloaded January 2011 150.007 NURSING SERVICES (G) Nursing and Supportive Routines and Practices. (2) No medication, treatment or therapeutic diet shall be administered to a patient or
More informationNOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
More informationMichigan Department of Licensing and Regulatory Affairs Bureau of Professional Licensing Board of Pharmacy PO Box 30670 Lansing MI 48909 (517)
Michigan Department of Licensing and Regulatory Affairs Bureau of Professional Licensing Board of Pharmacy PO Box 30670 Lansing MI 48909 (517) 373-8068 www.michigan.gov/bpl 1 MANUFACTURER/WHOLESALER LICENSE
More informationNurse-Managed Medication Inventory
Nurse-Managed Medication Inventory Information for Employers College of Registered Nurses of British Columbia 2855 Arbutus Street Vancouver, BC Canada V6J 3Y8 T: 604.736.7331 F: 604.738.2272 Toll-free:
More informationVILLANOVA UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY DEPARTMENT OF TRANSPORTATION HAZARDOUS MATERIALS SECURITY PLAN
VILLANOVA UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY DEPARTMENT OF TRANSPORTATION HAZARDOUS MATERIALS SECURITY PLAN Prepared by: Alice L. Lenthe, PE 24 April 2014 1 INTRODUCTION: The U.S. Transportation
More informationResource Directory for the Management of Pharmaceuticals in King County
Resource Directory for the Management of Pharmaceuticals in King County Interagency Regulatory Analysis Committee (IRAC) and Local Hazardous Waste Management Program in King County October 2003 SQG-PHARM-1(10/03)
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationGood Practice Guidance: The safe management of controlled drugs in care homes
Good Practice Guidance: The safe management of controlled drugs in care homes Medicines Management Social Care Support Team Reviewed April 2015 Good Practice Guidance: The safe management of controlled
More informationPHARMACY SECURITY BEST PRACTICES
CHRIS CHRISTIE Governor KIM GUADAGNO Lt. Governor Division of Consumer Affairs Office of the Director 124 Halsey Street, 7 th Floor, Newark NJ PHARMACY SECURITY BEST PRACTICES Published May 1, 2013 New
More informationWhat Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
More informationBoard of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015
Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement
More informationStatement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services
Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services Before The Special Committee on Aging United States Senate
More informationFREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationDEPARTMENT OF JUSTICE. Drug Enforcement Administration. 21 CFR Parts 1305, 1311. [Docket No. DEA-217F] RIN 1117-AA60
Billing code 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Parts 1305, 1311 [Docket No. DEA-217F] RIN 1117-AA60 Electronic Orders for Controlled Substances AGENCY: Drug Enforcement
More informationTHE DRUGS AND COSMETICS RULES, 1945
THE DRUGS AND COSMETICS RULES, 1945 PART VI SALE OF DRUGS OTHER THAN HOMOEOPATHIC MEDICINES 59. (1) The State Government shall appoint Licensing Authorities for the purpose of this Part for such areas
More information13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of
More informationU.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance
Guidance for Industry Prescription Drug Marketing Act Donation of Prescription Drug Samples to Free Clinics U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationCustodial Procedures Manual Table of Contents
Custodial Procedures Manual Table of Contents Page 1. Drug Policies and Procedures 1 A. Procurement of Prescription Drugs 1 i. Prescription drugs may only be accepted from 1 pharmacies and or practitioners.
More informationNUMBER: ISSUED: 04/08/09 REV. D: REV. E:
Policies and Procedures SECTION: CHAPTER: Individual Departments or Responsible Areas/Parties for Research Records POLICY: Retention of University Research and Compliance Records NUMBER: ISSUED: 04/08/09
More informationARKANSAS. Downloaded January 2011
ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel
More informationAchieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
More informationDRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES
1 DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES PURPOSE To provide guidelines for staff response when a client is found unconscious or not breathing. APPLICABILITY
More informationPharmaceutical Wholesaler Site Inspection Checklist
Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:
More informationEPA Comments on the Development of Safe and Effective Drug Collection and Disposal Methods
EPA Comments on the Development of Safe and Effective Drug Collection and Disposal Methods Robert W. Dellinger, Division Director Materials Recovery and Waste Management Division Office of Resource Conservation
More informationBOSTON COLLEGE ENVIRONMENTAL HEALTH AND SAFETY LABORATORY GUIDE FOR RENOVATIONS, REMODELS, MOVES AND TERMINATIONS
BOSTON COLLEGE ENVIRONMENTAL HEALTH AND SAFETY LABORATORY GUIDE FOR RENOVATIONS, REMODELS, MOVES AND TERMINATIONS I. Policy for Termination of Laboratory Use of Hazardous Materials The Principal Investigator
More informationINSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES
More informationDonald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules
D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of
More informationADMINISTRATION OF MEDICATIONS POLICY
Policy 6.007. ADMINISTRATION OF MEDICATIONS POLICY It is the policy of Cooperative Educational Services (C.E.S.) that students who require any medications to be administered during school hours, including
More informationRegistration FAQ How do I apply for a new OBNDD Registration or renew an existing one? A:
Registration FAQ Online Renewal Instructions How to Print Certificate or Update Address Registration FAQ How do I apply for a new OBNDD Registration or renew an existing one? A: If you want to apply for
More informationFREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION
FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION for the Revised: July 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationWASHINGTON LAWS, 1987
ensure compliance with this chapter and the treatment standard authorized by this chapter. A methadone treatment center shall not have a caseload in excess of three hundred fifty persons. The caseload
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationMUNICIPAL REGULATIONS for NURSE PRACTITIONERS
MUNICIPAL REGULATIONS for NURSE PRACTITIONERS CHAPTER 59 NURSE-PRACTITIONERS Secs. 5900 Applicability 5901 General Requirements 5902 Term of Certificate 5903 Renewal of Certificate 5904 Educational Requirements
More informationIMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
More informationRADIOACTIVE WASTE MANAGEMENT PLAN
RADIOACTIVE WASTE MANAGEMENT PLAN Copies of this plan will be made available to all members of the campus community with the potential to generate radioactive waste. Contents I. Purpose II. Regulatory
More informationQueen's University Environmental Health & Safety. 1. Introduction
1 1. Introduction The (WHMIS) was developed by the Department of Environmental Health & Safety in accordance with the University s Policy Statement on Health and Safety and to ensure compliance with the
More informationPREP WORKSHOP #11 Investigational Drug Disposal
PREP WORKSHOP #11 Investigational Drug Disposal Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, Clinical Research Service Miyuki Yoshida-Hay, RSO, MLSO, CHSP Safety Office,
More informationin The Institute of Internal Auditor's
Office of Internal Audit January 8, 2014 Dr. Kirk A. Calhoun, M.D. UT Health Northeastt 11937 U. S. Hwy 271 Tyler, TX 75708 Dr. Calhoun: The was completed as part off our Audit Plan. The objective of this
More informationGovernance of Controlled Drugs using Automated Cabinet-based Stock-control Systems
T: 0870 4328 250 F: 0870 4328 251 E: info@avantec.uk.com W: www.avantec.uk.com Governance of Controlled Drugs using Automated Cabinet-based Stock-control Systems An evaluation of ward practice and how
More informationHazardous Materials Management Considerations in Healthcare
Session No. 656 Introduction Hazardous Materials Management Considerations in Healthcare Mae Ping Grogg, MS, CSP BJC HealthCare St. Louis, MO 63110 Paul Halliburton, MS, CHMM Barnes-Jewish Hospital St.
More informationInventory Management
Inventory Management Chapter Outline Inventory Management Inventory Systems Computer & Inventory Ordering Forms Stocking & Storing Inventory Management Inventory A listing of medication of the goods or
More informationPharmaceutical Waste Compliance Program
Pharmaceutical Waste Compliance Program Corporate Overview Stericycle Services Medical Waste Management Sharps Disposal Management Product Recalls & Retrieval OSHA Compliance Training Pharmaceutical &
More informationPROPER DRUG SECURITY FOR THE FAIRBORN FD Howard 1
PROPER DRUG SECURITY FOR THE FAIRBORN FD Howard 1 Proper Drug Security for the Fairborn FD Adam D. Howard University of Cincinnati April 2014 Author Note This paper was prepared for the course on EMS Legal
More informationRMM 501 Hazardous Materials Management Systems Including WHMIS Program Page 2 November 2014
RMM 501 Hazardous Materials Management Systems Including WHMIS Program Page 2 3.4 McMaster University RMM #300 Safety Orientation and Training Program 3.5 McMaster University RMM #301 Standard Operating
More informationClinic Dispensing. By: Mark A. Horne, RPh, President PharmPak Inc.
Clinic Dispensing By: Mark A. Horne, RPh, President PharmPak Inc. Mark Horne, RPh President PharmPak, Inc. Education & Training: University of Arizona, Pharmacy Degree Licensure: California and Nevada
More informationOPERATIONS POLICY AND PROCEDURE
INTRODUCTION The San Ramon Valley Fire Protection District provides both First Responder Advanced Life Support (ALS) on the fire apparatus and ALS Ambulance transport. As an ALS provider, the District
More informationAppendix D. Criteria and Procedures for Model Home-Generated Pharmaceutical Waste Collection and Disposal Programs
Appendix D. Criteria and Procedures for Model Home-Generated Pharmaceutical Waste Collection and Disposal Programs Senate Bill 966 (Simitian, Chapter 542, Statutes of 2007) requires the California Integrated
More informationAnnex 9 Guide to good storage practices for pharmaceuticals 1
World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities
More informationREVIEW OF CHEMICAL SAFETY INVENTORY SYSTEM FEBRUARY 18, 2014
REVIEW OF CHEMICAL SAFETY INVENTORY SYSTEM FEBRUARY 18, 2014 OFFICE OF INTERNAL AUDIT BOX 19112 ARLINGTON, TX 76019-0112 817-272-0150 www.uta.edu/internalaudit MEMORANDUM: April 10, 2014 SUBJECT: Review
More informationCHAPTER 131. SENATE BILL No. 33
CHAPTER 131 SENATE BILL No. 33 AN ACT concerning the state board of pharmacy; pharmacy technicians; terms and membership of the state board of pharmacy; fingerprinting and criminal history record checks;
More informationSPILL RESPONSE PROCEDURE
SPILL RESPONSE PROCEDURE Queen's University Spill Response Procedure May 2000 1 SOP-HAZMAT-01 1.0 Preamble This document outlines emergency spill response procedures as part of the overall Queen's University
More informationDiscrepancies are claims that appear to have unusual or potentially abusive, wasteful or fraudulent elements (e.g., quantity, days supply).
Purpose: Provide guidelines for pharmacies for audits and appeals of pharmacy audit findings resulting from MedImpact auditor data review and claims selection for identification of potential fraud, waste
More informationEPA s proposed hazardous waste pharmaceutical regulations
EPA s proposed hazardous waste pharmaceutical regulations November 4, 2015 By J. Timothy Ramsey The United States Environmental Protection Agency ( EPA ) published proposed regulations in the Federal Register
More informationMUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS
MUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS CHAPTER 60 CLINICAL NURSE SPECIALIST Secs. 6000 Applicability 6001 General Requirements 6002 Term of Certificate 6003 Renewal of Certificate 6004 Educational
More informationINITIAL ECONOMIC IMPACT ANALYSIS OF THE PROPOSED ELECTRONIC ORDERS RULE. Drug Enforcement Administration U.S. Department of Justice
INITIAL ECONOMIC IMPACT ANALYSIS OF THE PROPOSED ELECTRONIC ORDERS RULE Drug Enforcement Administration U.S. Department of Justice March 11, 2003 3/11/03 TABLE OF CONTENTS EXECUTIVE SUMMARY... 1 CHAPTER
More informationConflicts of Interest. Disposal of Pharmaceutical Waste: What a Technician. Who is interested in proper pharmaceutical waste disposal?
Conflicts of Interest Disposal of Pharmaceutical Waste: What a Technician Should Know Presented by Michael McEvoy Pharm.D. NorthShore University HealthSystem The speaker has nothing to disclose in relation
More information